PlainRecalls
FDA Drug Moderate Class II Ongoing

FentaNYL citrate, 10 mcg in 0.9% Sodium Chloride 1 mL Vial (10 mcg/mL), 1.5 mL Total Volume per Vial, Intravenous, Rx Only, Hospital/Office Use Only, SSM Health Care Corporation Outsourcing Facility, 1015 Bowles Ave, Fenton, MO 63026-2394. NDC: 60652-9010-1

Reported: April 10, 2024 Initiated: February 29, 2024 #D-0436-2024

Product Description

FentaNYL citrate, 10 mcg in 0.9% Sodium Chloride 1 mL Vial (10 mcg/mL), 1.5 mL Total Volume per Vial, Intravenous, Rx Only, Hospital/Office Use Only, SSM Health Care Corporation Outsourcing Facility, 1015 Bowles Ave, Fenton, MO 63026-2394. NDC: 60652-9010-1

Reason for Recall

Lack of Assurance of Sterility: Firm did not perform process validation.

Details

Units Affected
140 vials
Distribution
MO
Location
Fenton, MO

Frequently Asked Questions

What product was recalled?
FentaNYL citrate, 10 mcg in 0.9% Sodium Chloride 1 mL Vial (10 mcg/mL), 1.5 mL Total Volume per Vial, Intravenous, Rx Only, Hospital/Office Use Only, SSM Health Care Corporation Outsourcing Facility, 1015 Bowles Ave, Fenton, MO 63026-2394. NDC: 60652-9010-1. Recalled by SSM Health Care St. Louis DBA SSM St. Clare Health Center. Units affected: 140 vials.
Why was this product recalled?
Lack of Assurance of Sterility: Firm did not perform process validation.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 10, 2024. Severity: Moderate. Recall number: D-0436-2024.